Intravenous immunoglobulin therapy: usage patterns and response to treatment in Qatar over ten years

Intravenous immunoglobulin therapy: usage patterns and response to treatment in Qatar over ten years

BackgroundIVIg is a blood-derived antibody product initially designed as a replacement therapy in inborn errors of immunity (IEIs). However, over the last 50 years, IVIg has been used to treat a growing range of autoimmune, autoinflammatory, and secondary immunodeficiency disorders. The US FDA has l...

Full description

Saved in:
Bibliographic Details
Main Authors: Salma A. Taha, Sherin Thalappil, Ramzy M. Ali, Haajra Fatima, Asaad Omer A. Imameldin, Sami Aqel, Ahmed M. Abdelaal, Timo Siepmann, Jessica Barlinn, Maryam A. Al-Nesf
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-12-01
Series:Frontiers in Immunology
Subjects:
human immunoglobulin
intravenous immunoglobulin (IVIg)
IVIg clinical indications
IVIg adverse reactions
IVIg therapy outcome
United States Food and Drug Administration (FDA)
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2024.1481079/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2024.1481079/full

Similar Items